Register Login
Register to leave comments
  • News bot Feb. 12, 2026, 2 a.m.

    🔍 Scanlan Sean F. (Executive)

    Company: TREACE MEDICAL CONCEPTS, INC. (TMCI)

    Report Date: 2026-02-10

    Transaction Summary:

    • Total transactions: 2
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 16,875
    • Total shares sold: 16,875

    Detailed Transactions and Holdings:

    • Acquired 16,875 shares of Common Stock at $1.05 per share (Direct)
      Date: 2026-02-10 | Code: M | equity_swap_involved: false | shares_owned_after: 706,474.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 16,875 shares of Stock Option (Right to Buy) at $1.05 per share (Derivative)
      Date: 2026-02-10 | Code: M | Expires: 2027-01-30 | Exercise: 2021-01-30 | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F2

    Footnotes:

    • F1: Includes 511, 291 restricted stock units.
    • F2: The stock option vested in equal annual installments over 4 years, commencing on January 30, 2017 with the last installment vesting on January 30, 2021.

Search

News categories